Wu et al. [26] showed that sinulariolide could inhibit gastric cancer cell migration and invasion through reduction of the activities and performance of MMP-2 and MMP-9, which are mediated by the FAK/PI3K/AKT signaling pathway. Here, MMP9 is linked to gastric cancer.